Word

JIXING

Status

Pending

Status Code

653

Status Date

Monday, January 22, 2024

Serial Number

97407895

Mark Type

3000

Filing Date

Thursday, May 12, 2022

Trademark Owner History

Ji Xing Pharmaceuticals (Shanghai) Co.,Ltd.

Classifications

5 Pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of asthma; cholesterol reducers; antihypertensives; anti-diabetic pharmaceuticals; anti-diabetic preparations; antiarrhythmics; cardiovascular pharmaceutical preparations; pharmaceutical preparation for eye or intraocular surgery; ophthalmic pharmaceutical products; ophthalmic preparations; medical preparations for use with eyes; medicines for the treatment of cardiovascular diseases; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; depuratives for the body; medicines for veterinary purposes, namely, veterinary diagnostic reagents, veterinary vaccines, Anti-infective products for veterinary use, and Veterinary preparations, namely, pain relief medication; Enzymes for veterinary purposes; biocides; disinfectant wipes; preparations to facilitate teething; diapers for pets; pharmaceutical candy, namely, medicated candies; medicines for human purposes, namely, human vaccine preparations, Antibiotics for human use, anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; pharmaceutical preparations, namely, pharmaceutical preparations for treatment of human illnesses, namely, heart disease and cancer; chemico-pharmaceutical preparations, namely, chemico-pharmaceutical preparations for treatment of human illnesses, namely, heart disease and cancer; ointments for pharmaceutical purposes, namely, antibiotic, sunburn, anti-inflammatory ointments for pharmaceutical purposes; bronchodilating preparations; injectable pharmaceuticals, namely, injectable pharmaceuticals for treatment of anaphylactic reactions; tablets for pharmaceutical purposes, namely, medicinal preparations for the mouth to be applied in the form of tablets and compressed tablets; tincture of iodine; herbal tinctures for medical purposes; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hypercholesterolemia

42 Scientific research and development; development of pharmaceutical preparations and medicines; biomedical research services; medical research services; chemical research; biotechnology research; drug testing services; Software as a service (SAAS) services featuring software for analyzing and reporting self-assessment of illness; Software as a service (SAAS) services, namely, hosting software for use by others for use in database management, use as a spreadsheet, word processing; pharmaceutical drug research services; pharmaceutical drug development services

The mark consists of the stylized word JIXING in green with the design of a broken heart to the left in color with the left side of the heart being orange and the right side being green with a helix in between the two sides.
The color(s) orange, green is/are claimed as a feature of the mark.

Trademark Events

Jan 22, 2024

Notification Of Letter Of Suspension E-Mailed

Jan 22, 2024

Letter Of Suspension E-Mailed

Jan 22, 2024

Suspension Letter Written

Jan 22, 2024

Teas/Email Correspondence Entered

Jan 22, 2024

Correspondence Received In Law Office

Jan 22, 2024

Assigned To Lie

Aug 30, 2023

Teas Response To Suspension Inquiry Received

Jun 8, 2023

Notification Of Inquiry As To Suspension E-Mailed

Jun 8, 2023

Inquiry To Suspension E-Mailed

Jun 8, 2023

Suspension Inquiry Written

Nov 30, 2022

Notification Of Letter Of Suspension E-Mailed

Nov 30, 2022

Letter Of Suspension E-Mailed

Nov 30, 2022

Suspension Letter Written

Nov 29, 2022

Teas/Email Correspondence Entered

Nov 29, 2022

Correspondence Received In Law Office

Nov 29, 2022

Teas Response To Office Action Received

May 31, 2022

Notification Of Non-Final Action E-Mailed

May 31, 2022

Non-Final Action E-Mailed

May 31, 2022

Non-Final Action Written

May 30, 2022

Assigned To Examiner

May 18, 2022

Notice Of Design Search Code E-Mailed

May 17, 2022

New Application Office Supplied Data Entered

May 16, 2022

New Application Entered